Editorial: Building Evidence to Manage Newborn Jaundice Worldwide
- Vinod K. Bhutani
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Newborn jaundice is universal and usually benign; but when progressive it can be effectively managed in any population through systematic screening (prenatal and postnatal) for identifiable risk factors, any attention to optimal breast milk intake and use of prophylactic phototherapy [1, 2]. Worldwide, about 14.1 million babies (about 10.5% of live births) annually are likely to require phototherapy (Fig. 1). Though use of phototherapy is evidence-based, proven, non-intrusive and non-expensive, more than 6 million (~45%) of at-risk infants do not have access to this life-saving and effective intervention . Conservatively, approximately 1.4 million infants sustain bilirubin >25 mg/dL (427 μmol/L) every year, an extreme level of over 99.9th percentile, that places them at an unacceptable high risk for the most easily preventable neonatal brain injury. At least 2.4 million (40%) infants represent those without access to phototherapy in Central and South Asia. Of these, an unknown numbe ...
- Subcommittee on Hyperbilirubinemia, American Academy of Pediatrics. Clinical Practice Guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316.
- Bhutani VK, Vilms RJ, Hamerman-Johnson L. Universal bilirubin screening for severe neonatal hyperbilirubinemia. J Perinatol. 2010;30:S6–15.
- Cline BK, Vilms V, McGraw K, Donaldson KM, Bhutani VK. Global Burden and Unmet Need for Hyperbilirubinemia Treatment. Pediatric Academic Societies 2011. Abstract #4503.92
- Maisels, MJ, Bhutani, VK, Bogen, D, Newman, TB, Stark, AR, Watchko, JF (2009) Hyperbilirubinemia in the newborn infant > or =35 weeks’ gestation: an update with clarifications. Pediatrics. 124: pp. 1193-1198 CrossRef
- Johnson, L, Bhutani, VK (2011) The clinical syndrome of bilirubin-induced neurologic dysfunction. Semin Perinatol. 35: pp. 101-113 CrossRef
- Arun Babu T, Bhat BV, Joseph NM. Association between peak serum bilirubin and neurodevelopmental outcomes in term babies with hyperbilirubinemia. Indian J Pediatr. 2011; doi:10.1007/s12098-011-0501-2
- Chawla D, Jain S, Dhir S, Rani S. Risk assessment strategy for prediction of pathological hyperbilirubinemia in neonates. Indian J Pediatr. 2011; doi:10.1007/s12098-011-0409-x
- Maisles MJ. Neonatal jaundice.In: Sinclair JC, Bracken MB eds. Effective care of the newborn infant .Oxford University Press. ISBN: 0-19-261737-0. 1992. pp. 507–61.
- Fallah R, Islami Z, Lotfi SR. Single dose of 50mg/kg clofibrate in jaundice of healthy term neonates : Randomized clinical trial of efficacy and safety. Indian J Pediatr. 2011; doi:10.1007/s12098-011-0531-9
- Silverman, WA (1994) The windermere lecture 1994. The line between ‘knowing’ and ‘doing’: medicine’s dilemma at the end of the twentieth century. Arch Dis Child. 71: pp. 261-265 CrossRef
- Editorial: Building Evidence to Manage Newborn Jaundice Worldwide
The Indian Journal of Pediatrics
Volume 79, Issue 2 , pp 253-255
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Vinod K. Bhutani (1)
- Author Affiliations
- 1. Division of Neonatal-Perinatal-Developmental Medicine, Department of Pediatrics, Lucile Packard Children’s Hospital, Stanford University School of Medicine, 750 Welch Ave, #315, Palo Alto, CA, 94304, USA